Hypoxia and the presence of human vascular endothelial cells affect prostate cancer cell invasion and metabolism

Neoplasia

Volumn 9, Issue 12, 2007, Pages 1138-1151

  Ackerstaff, Ellen ^a,c   Artemov, Dmitri ^a   Gillies, Robert J ^b   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Endothelial cancer cell interaction; Hypoxia; Invasion; Magnetic resonance (MR) imaging and spectroscopy; Prostate cancer

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; CANCER INVASION; CELL HYPOXIA; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROSTATE CANCER; VASCULAR ENDOTHELIUM;

EID: 37149023224     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07568     Document Type: Article

References (51)

1. Bissell MJ and Radisky D (2001). Putting tumours in context. Nat Rev Cancer 1, 46-54.
2. Liotta LA and Kohn EC (2001). The microenvironment of the tumour - host interface. Nature 411, 375-379.
3. Cairns RA, Khokha R, and Hill RP (2003). Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 3, 659-671.
4. Subarsky P and Hill RP (2003). The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 20, 237-250.
5. Friedl P and Brocker EB (2000). The biology of cell locomotion within three-dimensional extracellular matrix. Cell Mol Life Sci 57, 41-64.
6. Pouyssegur J, Dayan F, and Mazure NM (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437-443.
7. DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, et al. (2004). Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol 164, 1131-1139.
8. Skrzydlewska E, Sulkowska M, Koda M, and Sulkowski S (2005). Proteolytic - antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol 11, 1251-1266.
9. Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, and Bologna M (1998). Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin Exp Metastasis 16, 513-528.
10. Papandreou I, Powell A, Lim AL, and Denko N (2005). Cellular reaction to hypoxia: sensing and responding to an adverse environment. Mutat Res 569, 87-100.
11. Gehlsen KR, Wagner HN Jr, and Hendrix MJ (1984). Membrane invasion culture system (MICS). Med Instrum 18, 268-271.
12. Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, and Solaiyappan M (2001). Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 3, 143-153.
13. Pilatus U, Ackerstaff E, Artemov D, Mori N, Gillies RJ, and Bhujwalla ZM (2000). Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber. Neoplasia 2, 273-279.
14. Ackerstaff E, Gimi B, Artemov D, and Bhujwalla ZM (2007). Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line. Neoplasia 9, 222-235.
15. Webber MM, Bello D, and Quader S (1997). Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications, Part 2. Tumorigenic cell lines. Prostate 30, 58-64.
16. Gimi B, Mori N, Ackerstaff E, Frost EE, Bulte JW, and Bhujwalla ZM (2006). Noninvasive MRI of endothelial cell response to human breast cancer cells. Neoplasia 8, 207-213.
17. Kuzuya M, Satake S, Miura H, Hayashi T, and Iguchi A (1996). Inhibition of endothelial cell differentiation on a glycosylated reconstituted basement membrane complex. Exp Cell Res 226, 336-345.
18. Pathak AP, Gimi B, Glunde K, Ackerstaff E, Artemov D, and Bhujwalla ZM (2004). Molecular and functional imaging of cancer: advances in MRI and MRS. Methods Enzymol 386, 3-60.
19. Hewett PW and Murray JC (1993). Human microvessel endothelial cells: isolation, culture and characterization. In Vitro Cell Dev Biol Anim 29A, 823-830.
20. Semenza GL (2004). Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19, 176-182.
21. Graham CH, Forsdike J, Fitzgerald CJ, and Macdonald-Goodfellow S (1999). Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80, 617-623.
22. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, et al. (2003). Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63, 1138-1143.
23. He X, Brenchley PE, Jayson GC, Hampson L, Davies J, and Hampson IN (2004). Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies. Cancer Res 64, 3928-3933.
24. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, and Comoglio PM (2003). Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347-361.
25. Sato Y, Fujiwara H, Higuchi T, Yoshioka S, Tatsumi K, Maeda M, and Fujii S (2002). Involvement of dipeptidyl peptidase IV in extravillous trophoblast invasion and differentiation. J Clin Endocrinol Metab 87, 4287-4296.
26. Kilburn BA, Wang J, Duniec-Dmuchkowski ZM, Leach RE, Romero R, and Armant DR (2000). Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. Biol Reprod 62, 739-747.
27. Graham CH, Fitzpatrick TE, and McCrae KR (1998). Hypoxia stimulates urokinase receptor expression through a heme protein - dependent pathway. Blood 91, 3300-3307.
28. Krtolica A and Ludlow JW (1996). Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. Cancer Res 56, 1168-1173.
29. Boyden S (1962). Chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115, 453-466.
30. Sahai E (2005). Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15, 87-96.
31. Zeng ZZ, Jia Y, Hahn NJ, Markwart SM, Rockwood KF, and Livant DL (2006). Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor - mediated, matrix metalloproteinase-1 - dependent invasion by metastatic prostate cancer cells. Cancer Res 66, 8091-8099.
32. Sato H, Okada Y, and Seiki M (1997). Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost 78, 497-500.
33. Deryugina EI and Quigley JP (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25, 9-34.
34. Tachibana KE, Gonzalez MA, and Coleman N (2005). Cell-cycle - dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 205, 123-129.
35. Probst G, Riedinger HJ, Martin P, Engelcke M, and Probst H (1999). Fast control of DNA replication in response to hypoxia and to inhibited protein synthesis in CCRF-CEM and HeLa cells. Biol Chem 380, 1371-1382.
36. Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, and Lang SH (2001). Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer 84, 1417-1423.
37. Erecinska M and Silver IA (1994). Ions and energy in mammalian brain. Prog Neurobiol 43, 37-71.
38. Boutilier RG (2001). Mechanisms of cell survival in hypoxia and hypothermia. J Exp Biol 204, 3171-3181.
39. Warburg O (1956). Respiratory impairment in cancer cells. Science 124, 269-270.
40. Webster KA (2003). Evolution of the coordinate regulation of glycolytic enzyme genes by hypoxia. J Exp Biol 206, 2911-2922.
41. Macheda ML, Rogers S, and Best JD (2005). Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202, 654-662.
42. Uldry M and Thorens B (2004). The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch 447, 480-489.
43. Nithipatikom K, Isbell MA, Lindholm PF, Kajdacsy-Balla A, Kaul S, and Campell WB (2002). Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis 19, 593-601.
44. Ackerstaff E, Glunde K, and Bhujwalla ZM (2003). Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem 90, 525-533.
45. Zeisel SH (1993). Choline phospholipids: signal transduction and carcinogenesis. FASEB J 7, 551-557.
46. 2 inhibitor with potential anti-inflammatory activity. Nature 320, 77-81.
47. Glunde K, Jie C, and Bhujwalla ZM (2004). Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64, 4270-4276.
48. Mori N, Natarajan K, Chacko VP, Artemov D, and Bhujwalla ZM (2003). Choline phospholipid metabolites of human vascular endothelial cells altered by cyclooxygenase inhibition, growth factor depletion, and paracrine factors secreted by cancer cells. Mol Imaging 2, 124-130.
49. Coleman RA and Lee DP (2004). Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 43, 134-176.
50. Whitmer JT, Idell-Wenger JA, Rovetto MJ, and Neely JR (1978). Control of fatty acid metabolism in ischemic and hypoxic hearts. J Biol Chem 253, 4305-4309.
51. Goto K, Asai T, Hara S, Namatame I, Tomoda H, Ikemoto M, and Oku N (2005). Enhanced antitumor activity of xanthohumol, a diacylglycerol acyltransferase inhibitor, under hypoxia. Cancer Lett 219, 215-222.